ClinicalTrials.gg
RecruitingNCT07576127Updated May 8, 2026

Effects of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in Patients With Adhesive Capsulitis

An interventional study of Gongs Mobilization and Proprioceptive Neuromuscular Facilitation in Adhesive Capsulitis, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to female participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Sep 2025, registered May 2026).
  • Started Sep 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 52 studies in Bursitis by Riphah International University — 17 open to participants now, 17 under way, none of them phase 3. Bursitis · Riphah International University.

Planned enrollment
11th of 52
44 · median 38
Started
2025
with 7 others
No phase
52 of 52
17 open now
Primary completion
2026-05
later than 8 of 16 live
Registered
45th of 52
by date

Among the 52 studies in Bursitis by Riphah International University, this one is the 11th largest by planned enrollment, is one of 8 that started in 2025, is one of 52 with no phase, reaches primary completion later than 8 of the 16 other live ones, and was the 45th registered.

By phase

52 studies; the count open now beside each. This study's row is marked.

No phasethis study52 · 17 open

By the year they started

First in 2018; this study’s year is marked. 8 started in 2025.

Size and results

Median enrollment 38 across the 52 interventional studies. Of the 31 that completed or were terminated, 0 (0%) have results posted.

Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 52 studies in Bursitis by Riphah International University, or all of them as a file.
02

Study summary

The randomized controlled trail aims is to evaluate the outcome of Gongs mobilization and PNF in patients with adhesive capsulitis. The significance of this study is to compare Gong's mobilization technique with proprioceptive neuromuscular facilitation (PNF) compare their effects on pain, range of motion, and functional disability. The sample size was calculated with G-power. This study would include total 44 female participants aged 40-60 years will be recruited and randomly assigned to two groups. Group A(Gongs mobilization+ conventional therapy)and Group B(PNF+ Conventional therapy). Intervention will be provided for 4 weeks 3 session per week. Primary outcome measures are pain, ROM and functional disability via NPRS, Goniometer and U-SPADI. Outcomes will be reassessed at baseline, after 2nd week, and after 4th week.

Read the detailed description

Adhesive capsulitis ,which is also referred as frozen shoulder is described as a progressive and self-limiting condition leading to gradual onset of pain and loss of shoulder Range of motion. It restricts both Active and Passive movements due to adhesions in Glenohumeral(GH) joint capsule. which leads to fibrosis, scarring and contracture of joint capsule. As fibrosis progresses restricting the shoulder normal Range of motion. ultimately impacting person's daily activities and frequently interfering with sleep and making basic activities like combing hair , dressing and overhead activities difficult.

Gong's Mobilization(GM) serves as an effective technique in the treatment of Frozen shoulder, it was introduced by W. Gong, the mainstay of this mobilization is to correct the positional fault of the humeral head that is often medially rotated and dragged forward due to muscular tension of Subscapularis and Pectoralis Major along with the tightness of posterior capsule. Gong mobilization intends to keep the humeral head in its correct position during dynamic motion of the GH joint by keeping the affected scapula in anterior to posterior position and the humeral head in posterior to anterior direction at the same time. Proprioceptive neuromuscular facilitation (PNF) stretch is a technique commonly used in clinical environments to enhance both active and passive range of motion (ROM), with the ultimate goal of optimizing motor performance and rehabilitation

03

Conditions studied

  • Adhesive Capsulitis

Browse trials for

Keywords

  • Pain
  • ROM
  • Functional Disability
  • Gongs Mobilization
  • PNF
04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Females in the age group between 40-60 years.
  • Diagnosed with Unilateral frozen shoulder.
  • Patients in frozen stage (progressive loss of ROM, marked stiffness with gradual pain reduction).
  • More than 25% painful limitation of GH ROM in two planes, more than 50% in external rotation(arm at 0 degree of abduction).

Exclusion criteria

Exclusion Criteria:

  • History of surgery on the affected shoulder.
  • Patients having any cervical or thoracic problem.
  • Painful, stiff shoulder after severe trauma, inflammatory diseases such as rheumatoid arthritis and .
  • Recent fractures in and around the shoulder.
  • Rotator cuff disorder.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Gongs Mobilization

    Gongs Mobilization + conventional Therapy

    Behavioral: Gongs Mobilization · Behavioral: Proprioceptive Neuromuscular Facilitation

  • Experimental
    Proprioceptive Neuromuscular facilitation

    PNF + conventional Therapy

    Behavioral: Gongs Mobilization · Behavioral: Proprioceptive Neuromuscular Facilitation

Interventions

  • BehavioralGongs Mobilization

    Glenohumeral mobilization (GM) will be performed in a side-lying position with the therapist standing on the affected side. An anterior-to-posterior glide will be applied to the humeral head parallel to the joint plane while the opposite hand stabilizes the scapula from posterior to anterior. The patient will perform quick shoulder abduction movements with the elbow extended as the therapist applies Maitland's Grade III-IV oscillatory glides, maintaining slight joint distraction and following the motion through the abduction phase. Each session will include two sets of five repetitions with a five-minute rest between sets, for a total of twelve sessions

  • BehavioralProprioceptive Neuromuscular Facilitation

    The therapist will use proprioceptive neuromuscular facilitation (PNF) techniques specifically employing the hold-relax method followed by the D2 pattern of flexion-extension movement. Each session will last 15 minutes, comprising 10 sets of PNF. Each set will include 5 repetitions, with a 5-second hold and a 2-second rest between repetitions. This protocol will be administered over 12 sessions.

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale

    Numeric pain rating scale is Subjective Assessment Tool used to assess level of discomfort patients are experiencing. It is eleven-point scale (0-10).whereas 0 indicates(no pain at all) and 10 indicates(worst imaginable pain).

    Time frame: 4 weeks

  2. Goniometer

    Universal goniometer is used to assess active and passive Range of motion

    Time frame: 4 weeks

  3. Shoulder pain and Disability Index Urdu version(SPADI-U)

    SPADI-U was Created to assess degree of pain and discomfort in carrying out activities of daily living by patients without any assistance. In the recent version 11-Point Numeric pain rating scale is used to rate each item. It has total 13 items, 5-items for evaluating pain and 8-items for disability.

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Kim DH. Outcome Measurement in Shoulder Diseases: Focus on Shoulder Pain and Disability Index (SPADI). Ann Rehabil Med. 2023 Oct;47(5):315-317. doi: 10.5535/arm.23130. Epub 2023 Oct 25. No abstract available. PubMed 37907222 ↗
  • Khan AH, Bhuiyan MSH, Kabir MF, Hossain MZ, Jahan S, Hossain KMA, Rahman E. Effectiveness of proprioceptive neuromuscular facilitation pattern on upper extremity and scapula in patients with adhesive capsulitis: a single-centre assessor-blinded randomised controlled trial (RCT). Trials. 2025 May 3;26(1):146. doi: 10.1186/s13063-025-08848-0. PubMed 40317031 ↗
  • Fernandes MR. Adhesive capsulitis: current concepts. Musculoskelet Surg. 2026 Mar;110(1):1-10. doi: 10.1007/s12306-025-00897-7. Epub 2025 Mar 17. PubMed 40095380 ↗
  • Amjad F, Asghar H. Comparative effects of gong's mobilization and mobilization with movement in patients with adhesive capsulitis: a randomized clinical trial. Sci Rep. 2025 Feb 4;15(1):4272. doi: 10.1038/s41598-025-88422-5. PubMed 39905175 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07576127
Responsible party
Sponsor
First posted
May 8, 2026
Start date
Sep 1, 2025
Primary completion
May 5, 2026 (estimated)
Completion
May 15, 2026 (estimated)
Last update
May 8, 2026

Study contacts

Fatima Miraj, DPT
Contact
fatimamiraj921@gmail.com
+923045938254
Attiq ur Rehman, MS
Contact
attiq.rehman@riphah.edu.pk
+92-336-1055533
Fatima Miraj, DPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion